iShares Biotechnology ETF
955 hedge funds and large institutions have $6.37B invested in iShares Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 184 funds opening new positions, 304 increasing their positions, 248 reducing their positions, and 66 closing their positions.
Holders
955
Holders Change
+105
Holders Change %
+12.35%
% of All Funds
14.75%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.15%
New
184
Increased
304
Reduced
248
Closed
66
Calls
$453M
Puts
$409M
Net Calls
+$43.6M
Net Calls Change
+$34.3M
Top Buyers
| 1 |
1
Citigroup
New York
|
$244M |
| 2 |
2
Morgan Stanley
New York
|
$580M |
| 3 |
E
3
Ergoteles
New York
|
$33.7M |
| 4 |
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
$200M |
| 5 |
DC
5
DeDora Capital
Napa,
California
|
$24.8M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1026
Scoggin Management
New York
| – | – | – | – |
|
|
SFA
1027
Semmax Financial Advisors
Winston Salem,
North Carolina
| $0 | 1 | – | – |
|
|
OAJ
1028
Ogorek Anthony Joseph
Williamsville,
New York
| – | – | – | – |
|
|
PCM
1029
Prelude Capital Management
New York
| – | – | – | – |
|
1030
IMC Chicago
Chicago,
Illinois
| – | – | – | – |
|
1031
Capstone Investment Advisors
New York
| $0 | 3 | – | – |
|
|
CIAS
1032
CBIZ Investment Advisory Services
Independence,
Ohio
| – | – | – | – |
|
1033
Marshall Wace
London,
United Kingdom
| – | – | – | – |
|
|
FMP
1034
Financial Management Professionals
Austin,
Texas
| $0 | 3 | +3 | New |
|